BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12677287)

  • 1. Acute myocardial infarction and cardiac arrest in a patient receiving paclitaxel.
    Nguyen-Ho P; Kleiman NS; Verani MS
    Can J Cardiol; 2003 Mar; 19(3):300-2. PubMed ID: 12677287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential versus concurrent paclitaxel and carboplatin for the treatment of advanced non-small cell lung cancer in elderly patients and patients with poor performance status: results of two Phase II, multicenter trials.
    Marsland TA; Garfield DH; Khan MM; Look RM; Boehm KA; Asmar L
    Lung Cancer; 2005 Jan; 47(1):111-20. PubMed ID: 15603861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel-induced myocardial infarction in a case of carcinoma ovary.
    Londhey VA; Parikh FS
    J Assoc Physicians India; 2009 Apr; 57():342-3. PubMed ID: 19702043
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer.
    Ceresoli GL; Gregorc V; Cordio S; Bencardino KB; Schipani S; Cozzarini C; Bordonaro R; Villa E
    Lung Cancer; 2004 May; 44(2):231-9. PubMed ID: 15084388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Paclitaxel].
    Díaz M; Campanero MA
    Rev Med Univ Navarra; 1996; 40(3):43-51. PubMed ID: 9499826
    [No Abstract]   [Full Text] [Related]  

  • 6. Symptoms and signs of an acute myocardial ischemia caused by chemotherapy with Paclitaxel (Taxol) in a patient with metastatic ovarian carcinoma.
    Schrader C; Keussen C; Bewig B; von Freier A; Lins M
    Eur J Med Res; 2005 Nov; 10(11):498-501. PubMed ID: 16354605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer.
    Charoentum C; Thongprasert S; Chewasakulyong B
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1603-7. PubMed ID: 17940374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956).
    Scagliotti GV; Smit E; Bosquee L; O'Brien M; Ardizzoni A; Zatloukal P; Eberhardt W; Smid-Geirnaerdt M; de Bruin HG; Dussenne S; Legrand C; Giaccone G;
    Lung Cancer; 2005 Oct; 50(1):91-6. PubMed ID: 16019107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of cisplatin analogue nedaplatin (254-S) and paclitaxel in patients with unresectable squamous cell carcinoma.
    Sekine I; Nokihara H; Horiike A; Yamamoto N; Kunitoh H; Ohe Y; Tamura T; Kodama T; Saijo N
    Br J Cancer; 2004 Mar; 90(6):1125-8. PubMed ID: 15026789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Safety evaluation of adjuvant chemotherapy by weekly paclitaxel combined with weekly carboplatin in patients with postoperative non-small cell lung cancer].
    Hirose T; Nagao T; Kajikawa A; Sumi T; Sugimoto T; Hirose Y; Yoshida M; Kenzaki K
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1397-400. PubMed ID: 17876136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.
    Davies AM; Chansky K; Lau DH; Leigh BR; Gaspar LE; Weiss GR; Wozniak AJ; Crowley JJ; Gandara DR;
    J Clin Oncol; 2006 Nov; 24(33):5242-6. PubMed ID: 17114656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of paclitaxel administration on P wave duration and dispersion.
    Barutcu I; Sezgin AT; Gullu H; Esen AM; Ozdemir R
    Clin Auton Res; 2004 Feb; 14(1):34-8. PubMed ID: 15045599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aeroportia and necrotizing enteritis after chemotherapy with paclitaxel for lung carcinoma].
    Benoit L; Favoulet P; Fraisse J; Feutray S; Collin F; Chauffert B; Cuisenier J
    Gastroenterol Clin Biol; 2003 Apr; 27(4):423-4. PubMed ID: 12759687
    [No Abstract]   [Full Text] [Related]  

  • 14. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
    Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weekly paclitaxel for advanced non-small cell lung cancer patients not suitable for platinum-based therapy.
    Juan O; Albert A; Villarroya T; Sánchez R; Casan R; Caranana V; Campos JM; Alberola V
    Neoplasma; 2003; 50(3):204-9. PubMed ID: 12937854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse effects of paclitaxel in patients with alcohol abuse histories.
    Henderson-Martin B
    Clin J Oncol Nurs; 2000; 4(1):11-4. PubMed ID: 10865578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of acute myocardial infarction during 5-fluorouracil infusion.
    Canale ML; Camerini A; Stroppa S; Porta RP; Caravelli P; Mariani M; Balbarini A; Ricci S
    J Cardiovasc Med (Hagerstown); 2006 Nov; 7(11):835-7. PubMed ID: 17060812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac dysfunction in cancer patients receiving paclitaxel.
    Valdés Olmos RA; ten Bokkel Huinink WW; Hoefnagel CA
    Eur J Nucl Med; 1998 Apr; 25(4):446-7. PubMed ID: 9643974
    [No Abstract]   [Full Text] [Related]  

  • 19. Pilot phase II study of weekly chemotherapy with paclitaxel and carboplatin for refractory or relapsed small-cell lung cancer.
    Mori K; Kamiyama Y; Kondo T; Kano Y; Kodama T
    Cancer Chemother Pharmacol; 2006 Jul; 58(1):86-90. PubMed ID: 16447041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730).
    Lilenbaum RC; Herndon JE; List MA; Desch C; Watson DM; Miller AA; Graziano SL; Perry MC; Saville W; Chahinian P; Weeks JC; Holland JC; Green MR
    J Clin Oncol; 2005 Jan; 23(1):190-6. PubMed ID: 15625373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.